Alexion Access Foundation
Private foundation · New Haven, CT · EIN 20-8963321 · reported 2023–2025
16grants reported
$20.4Mmedian award
$3.4Mlower quartile
$121Ksmallest grant
$386.9Mtotal paid
1states reached
3years giving
Gives every year. This foundation reported grants in 2023, 2024, 2025. A funder that shows up year after year is worth a letter even if this year is a no.
Who they funded
| Recipient and stated purpose | Where | Amount |
|---|---|---|
| Vials OF Strensiq Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $70,366,296 |
| Vials OF Strensiq Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $57,544,344 |
| Vials OF Ultomiris Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $52,034,549 |
| Vials OF Ultomiris Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $45,030,794 |
| Vials OF Strensiq Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $36,694,944 |
| Vials OF Soliris Were Distributed T PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $36,687,708 |
| Vials OF Ultomiris Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $25,637,347 |
| Vials OF Soliris Were Distributed T PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $22,621,764 |
| Vials OF Soliris Were Distributed T PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $18,133,940 |
| Vials OF Koselugo Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $7,299,824 |
| Vials OF Kanuma Were Distributed TO PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $3,920,640 |
| Vials OF Koselugo Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $3,644,245 |
| Vials OF Koselugo Were Distributed PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $3,442,401 |
| Vials OF Kanuma Were Distributed TO PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $3,093,630 |
| Vials OF Kanuma Were Distributed TO PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $581,970 |
| Vials OF Voydeya Were Distributed T PROVIDE ALEXION PRODUCT AT NO CHARGE TO ELIGIBLE PATIENTS WHO ARE UNABLE TO AFFORD THE PRESCRIBED PR | New Haven, CT | $121,176 |
Which foundations would fund your organization?
Tell us what you do, where you are and how big you are. We search 4,436,666 reported grants and hand back the foundations that already funded organizations like yours, at a size you can actually win.
Get your funder match — $29